Dr. Christopher J. Lesar, M.D.
Vascular Surgery (Vascular Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Medical College of Ohio (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 992
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: Medical College of Ohio
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
TN license 37354
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Healthcare System, Inc Chattanooga, TN
- Parkridge Medical Center Chattanooga, TN
Medical groups
- Vascular Institute of Chattanooga, PLLC (19 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 992
- Services billed
- 3,608
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, fentanyl citrate, 0.1 mg | 4,938 | 111 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,867 | 86 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,598 | 40 |
| Injection, midazolam hydrochloride, per 1 mg | 482 | 119 |
| Ultrasound study of arm and leg arteries | 327 | 290 |
| Ultrasound of leg arteries or artery grafts | 319 | 292 |
| Ultrasound of both sides of head and neck blood flow | 311 | 293 |
| Ultrasonic guidance for blood vessel access | 281 | 176 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 281 | 269 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 236 | 189 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Chattanooga, TN | 524 |
| Xarelto (rivaroxaban) Other prescribers in Chattanooga, TN | 355 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Chattanooga, TN | 86 |
| Eliquis (apixaban) Other prescribers in Chattanooga, TN | 62 |
| Cilostazol Other prescribers in Chattanooga, TN | 49 |
| Methylprednisolone Other prescribers in Chattanooga, TN | 47 |
| Famotidine Other prescribers in Chattanooga, TN | 45 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 41 payments worth $32,164 in total to this clinician.
| Bard Peripheral Vascular, Inc. | $21,997 |
|---|---|
| Terumo Medical Corporation | $6,678 |
| Cordis US Corp. | $1,871 |
| Veryan Medical Incorporated | $940 |
| Becton, Dickinson and Company | $203 |
| Abbott Laboratories | $135 |
| Stryker Corporation | $101 |
| W. L. Gore & Associates, Inc. | $50.20 |
| Consulting Fee | $28,106 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $1,600 |
| Food and Beverage | $1,256 |
| Travel and Lodging | $1,201 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Bard Peripheral Vascular, Inc. Jan 9, 2025 | Consulting Fee | $9,775 |
| Bard Peripheral Vascular, Inc. Oct 27, 2025 | Consulting Fee | $7,188 |
| Terumo Medical Corporation Aug 21, 2025 | Consulting Fee | $4,000 |
| Bard Peripheral Vascular, Inc. Apr 14, 2025 | Consulting Fee | $3,450 |
| Terumo Medical Corporation Apr 21, 2025 | Consulting Fee | $1,650 |
| Bard Peripheral Vascular, Inc. Feb 3, 2025 | Travel and Lodging travel to CHATTANOOGA, TN · in-kind | $1,201 |
| Cordis US Corp. Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) MYNX CONTROL VENOUS · Cardiology/Vascular Diseases | $1,200 |
| Terumo Medical Corporation Aug 21, 2025 | Consulting Fee | $1,000 |
| Veryan Medical Incorporated Nov 2, 2025 | Consulting Fee BioMimics 3D Vascular Stent System · Vascular Stent | $900 |
| Cordis US Corp. Sep 26, 2025 | Compensation for services other than consulting (speaking, faculty) MYNX CONTROL VENOUS · Cardiology/Vascular Diseases | $400 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Veryan Medical Incorporated Nov 2, 2025 | Consulting Fee BioMimics 3D Vascular Stent System · Vascular Stent | $900 |
| Bard Peripheral Vascular, Inc. Oct 27, 2025 | Consulting Fee | $7,188 |
| Cordis US Corp. Sep 26, 2025 | Compensation for services other than consulting (speaking, faculty) MYNX CONTROL VENOUS · Cardiology/Vascular Diseases | $400 |
| Cordis US Corp. Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) MYNX CONTROL VENOUS · Cardiology/Vascular Diseases | $1,200 |
| Bard Peripheral Vascular, Inc. Aug 27, 2025 | Consulting Fee | $144 |
| Terumo Medical Corporation Aug 21, 2025 | Consulting Fee | $4,000 |
| Terumo Medical Corporation Aug 21, 2025 | Consulting Fee | $1,000 |
| Terumo Medical Corporation Apr 21, 2025 | Consulting Fee | $1,650 |
| Bard Peripheral Vascular, Inc. Apr 14, 2025 | Consulting Fee | $3,450 |
| Bard Peripheral Vascular, Inc. Feb 3, 2025 | Travel and Lodging travel to CHATTANOOGA, TN · in-kind | $1,201 |
| Bard Peripheral Vascular, Inc. Jan 9, 2025 | Consulting Fee | $9,775 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $7,984 in research payments for these studies, mostly to the institutions running them.
- CONNECT-AV
Bard Peripheral Vascular, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.